Internal Medicine, Gastroenterology · Forest Hills, NY
NPI
1922055276
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
10816 72nd Ave, 2 Floor
Forest Hills, NY, 11375
Phone (718) 261-0900
Groups this clinician bills Medicare through
Medicare paid, 2024
$206K
5,916 services
Medicare patients, 2024
613
Average age 74
Drug cost, 2024
$3.0M
5,318 prescriptions
Company payments, 2025
$27K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel Davidoff was code 95004 (test - miscellaneous), 3,968 times for 62 patients. In total Samuel Davidoff billed 5,916 services in 30 codes, and Medicare paid $206K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 3,968 | 62 | $3.26 | $13K |
| 99213 Office E&M - Established | Office | 418 | 291 | $75.72 | $32K |
| 99203 Office E&M - New | Office | 186 | 186 | $86.99 | $16K |
| 99214 Office E&M - Established | Office | 183 | 158 | $104.63 | $19K |
| 44376 Digestive/Gastrointestinal | Office | 134 | 134 | $117.96 | $16K |
| 88305 Surgical Pathology Examination | Office | 101 | 28 | $30.75 | $3,106 |
| 43239 Upper GI Endoscopy | Office | 100 | 100 | $309.11 | $31K |
| 45385 Colonoscopy - Lesion Removal | Office | 88 | 88 | $385.91 | $34K |
| 88313 Surgical Pathology Examination | Office | 75 | 19 | $12.98 | $974 |
| 36410 Vascular | Office | 59 | 51 | $14.63 | $863 |
| 88342 Immunohistochemistry | Office | 55 | 19 | $29.94 | $1,646 |
| 45380 Lower GI Endoscopy - Other | Office | 49 | 49 | $194.09 | $9,511 |
| 99204 Office E&M - New | Office | 48 | 48 | $133.77 | $6,421 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 26 | 26 | $366.20 | $9,521 |
| 88312 Surgical Pathology Examination | Office | 24 | 18 | $30.66 | $736 |
By year: 2022 $186K for 1,890 services; 2023 $200K for 4,076 services; 2024 $206K for 5,916 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 101 | 28 | $30.75 | $3,106 |
| 88313 Surgical Pathology Examination | 75 | 19 | $12.98 | $974 |
| 88342 Immunohistochemistry | 55 | 19 | $29.94 | $1,646 |
| 88312 Surgical Pathology Examination | 24 | 18 | $30.66 | $736 |
| 83014 Clinical Chemistry | 22 | 21 | $7.70 | $169 |
Medicare prescription drug claims, 2024
In 2024, the drug Samuel Davidoff prescribed most often to Medicare patients was Linzess (Linaclotide), with 921 prescriptions and refills. In total Samuel Davidoff wrote 5,318 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Linzess Linaclotide | 921 | 992 | 177 | $501K |
| Omeprazole Generic | 743 | 913 | 203 | $3,766 |
| Dexilant Dexlansoprazole | 363 | 381 | 63 | $110K |
| Famotidine Generic | 347 | 413 | 107 | $8,404 |
| Dicyclomine Hcl Generic | 268 | 288 | 120 | $3,950 |
| Creon Lipase/Protease/Amylase | 261 | 274 | 59 | $305K |
| Pantoprazole Sodium Generic | 228 | 296 | 60 | $1,060 |
| Dexlansoprazole Dr Dexlansoprazole | 226 | 264 | 55 | $39K |
| Amitriptyline Hcl Generic | 206 | 230 | 54 | $525 |
| Zenpep Lipase/Protease/Amylase | 174 | 192 | 31 | $337K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 167 | 167 | 164 | $9,554 |
| Trulance Plecanatide | 132 | 134 | 19 | $70K |
| Nexium Esomeprazole Magnesium | 119 | 129 | 18 | $33K |
| Ibsrela Tenapanor Hcl | 115 | 115 | 24 | $192K |
| Esomeprazole Magnesium Generic | 93 | 123 | 25 | $2,093 |
Brand drugs: 2,675 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samuel Davidoff $27K ($27K in general payments such as food, travel and fees) from 19 companies. The largest payer was Gilead Sciences, Inc. with $10K.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 21 | $10K |
| Abbvie Inc. ABBV | 32 | $8,547 |
| Madrigal Pharmaceuticals MDGL | 16 | $4,679 |
| Celltrion USA Inc. 068270.KS | 13 | $682 |
| Ardelyx, Inc. ARDX | 13 | $565 |
| Janssen Biotech, Inc. JNJ | 19 | $477 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 14 | $368 |
| Lilly USA, LLC LLY | 7 | $270 |
| Aimmune Therapeutics, Inc. | 10 | $265 |
| QOL Medical, LLC | 8 | $222 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.